Autoimmune Disease Diagnostics Market Growth Fueled by Rising Disease Incidence

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Autoimmune Disease Diagnosis Market Between 2026 And 2030?

The autoimmune disease diagnosis market size has witnessed strong growth in recent years. It is projected to increase from $6.2 billion in 2025 to $6.74 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.8%. Historically, this expansion can be ascribed to the increasing prevalence of autoimmune diseases, improved availability of immunoassay technologies, the expansion of clinical laboratory networks, growing physician awareness of autoimmune conditions, and wider adoption of routine screening tests.

The autoimmune disease diagnosis market is projected to experience robust expansion over the coming years. This market is set to reach $9.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. Factors contributing to this growth during the forecast period include a heightened need for early and precise diagnosis, the escalating adoption of AI-assisted diagnostic analytics, the broadening of personalized diagnostic strategies, increased funding for autoimmune research, and the greater incorporation of point-of-care testing solutions. Key trends anticipated during this period encompass the wider embrace of sophisticated immunological testing, the growing application of autoantibody panels, the increasing integration of multiplex diagnostic platforms, the expansion of laboratory automation, and an intensified focus on identifying diseases at earlier stages.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Which Drivers Are Supporting The Autoimmune Disease Diagnosis Market Growth?

The increasing occurrence of autoimmune diseases has fueled the expansion of the autoimmune disease diagnosis market. These conditions involve the body’s immune system erroneously targeting its own healthy cells, tissues, or organs. Their rise is attributed to greater exposure to environmental factors like pollution and infections, alongside lifestyle modifications that interfere with immune regulation. Accurate diagnosis of autoimmune diseases is crucial for pinpointing the exact immune disorder, enabling effective treatment initiation and improved management of disease progression. For example, the Society for Women’s Health Research, a U.S.-based non-profit, estimated in March 2023 that autoimmune diseases affect between 23.5 million and 50 million individuals. Moreover, global autoimmune disease rates are seeing an annual increase of 3-9 percent. Consequently, the growing global incidence of autoimmune diseases is a primary catalyst for the growth of the autoimmune disease diagnosis market.

How Is Segmentation Applied In The Autoimmune Disease Diagnosis Market Segment Analysis?

The autoimmune disease diagnosis market covered in this report is segmented –

1) By Product: Consumables And Assay Kits, Instruments

2) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests

3) By End User: Clinical Laboratories, Hospitals, Other End Users

Subsegments:

1) By Consumables And Assay Kits: ELISA Kits, Reagents And Test Kits, Sample Collection And Preservation Devices, Control And Calibration Materials

2) By Instruments: Immunoassay Analyzers, Flow Cytometers, Luminometers, Microscopes

Which Trends Are Expected To Impact The Autoimmune Disease Diagnosis Market?

Major companies within the autoimmune disease diagnosis market are focusing on developing technological advancements, such as multiplex autoantibody assay platforms, aimed at achieving comprehensive, early, and precise detection of autoimmune disorders to enhance diagnostic accuracy and patient management. These multiplex autoantibody assay platforms facilitate the simultaneous detection of multiple disease-specific autoantibodies within a single patient sample, thereby improving sensitivity and specificity compared to traditional single-analyte ELISA or immunofluorescence tests, while also reducing the required sample volume and turnaround time. For example, in January 2025, Exagen Inc., a U.S.-based diagnostics company, introduced its AVISE CTD platform, featuring new systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) biomarker assays. This platform is capable of detecting novel biomarkers like TIgG, TIgM, and TC4d, allowing clinicians to more accurately distinguish overlapping autoimmune conditions and streamline patient diagnosis, all while integrating seamlessly with existing testing workflows.

Who Are The Companies Participating In The Autoimmune Disease Diagnosis Market Environment?

Major companies operating in the autoimmune disease diagnosis market are Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc, bioMérieux SA, SQI Diagnostics, Philips Healthcare India, Agappe Diagnostics Ltd, Lepu Medical Technology Company (Beijing) Co., Ltd, Shanghai Runda Medical Technology Co., Ltd, GE Healthcare China Co., Ltd, Roche Holding AG, Koninklijke Philips, Theradiag, Becton Dickinson and Company, Ortho Clinical Diagnostics

Get The Full Autoimmune Disease Diagnosis Market Report:

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Which Region Accounts For The Largest Portion Of The Autoimmune Disease Diagnosis Market?

North America was the largest region in the autoimmune disease diagnosis market in 2025. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Autoimmune Disease Diagnosis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Browse Through More Reports Similar to the Global Autoimmune Disease Diagnosis Market 2026, By The Business Research Company

Veterinary Autoimmune Disease Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-autoimmune-disease-therapeutics-global-market-report

Autoimmune Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Immunodiagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795